352 related articles for article (PubMed ID: 20010493)
61. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J
Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172
[TBL] [Abstract][Full Text] [Related]
62. The lack of association between components of metabolic syndrome and treatment resistance in depression.
Sagud M; Mihaljevic-Peles A; Uzun S; Cusa BV; Kozumplik O; Kudlek-Mikulic S; Mustapic M; Barisic I; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2013 Nov; 230(1):15-21. PubMed ID: 23579429
[TBL] [Abstract][Full Text] [Related]
63. Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Castro-Marrero J; Domingo JC; Cordobilla B; Ferrer R; Giralt M; Sanmartín-Sentañes R; Alegre-Martín J
Antioxid Redox Signal; 2022 Apr; 36(10-12):729-739. PubMed ID: 35229657
[TBL] [Abstract][Full Text] [Related]
64. Plasma coenzyme Q10 concentrations are not decreased in male patients with coronary atherosclerosis.
van de Vijver LP; Weber C; Kardinaal AF; Grobbee DE; Princen HM; van Poppel G
Free Radic Res; 1999 Mar; 30(3):165-72. PubMed ID: 10711786
[TBL] [Abstract][Full Text] [Related]
65. Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study.
Coppadoro A; Berra L; Kumar A; Pinciroli R; Yamada M; Schmidt UH; Bittner EA; Kaneki M
J Crit Care; 2013 Oct; 28(5):571-6. PubMed ID: 23618779
[TBL] [Abstract][Full Text] [Related]
66. Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction.
Yang YK; Wang LP; Chen L; Yao XP; Yang KQ; Gao LG; Zhou XL
Clin Chim Acta; 2015 Oct; 450():83-9. PubMed ID: 26254995
[TBL] [Abstract][Full Text] [Related]
67. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.
Lesser GJ; Case D; Stark N; Williford S; Giguere J; Garino LA; Naughton MJ; Vitolins MZ; Lively MO; Shaw EG;
J Support Oncol; 2013 Mar; 11(1):31-42. PubMed ID: 22682875
[TBL] [Abstract][Full Text] [Related]
68. Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy.
Seneş M; Erbay AR; Yilmaz FM; Topkaya BC; Zengi O; Doğan M; Yücel D
Clin Chem Lab Med; 2008; 46(3):382-6. PubMed ID: 18254715
[TBL] [Abstract][Full Text] [Related]
69. Coenzyme Q10 Supplementation in Fibrosis and Aging.
Hargreaves IP; Mantle D
Adv Exp Med Biol; 2019; 1178():103-112. PubMed ID: 31493224
[TBL] [Abstract][Full Text] [Related]
70. The Influence of Atorvastatin, Amlodipine and Ethoxidol on Ubiquinol and Ubiquinone Endogenous Plasma Concentrations in Patients with Chronic Heart Failure.
Zozina VI; Kondratenko SN; Shikh EV; Krasnykh LM; Melnikov ES; Kukes VG
Curr Drug Metab; 2023; 24(9):635-644. PubMed ID: 37711113
[TBL] [Abstract][Full Text] [Related]
71. Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.
Morris G; Anderson G; Berk M; Maes M
Mol Neurobiol; 2013 Dec; 48(3):883-903. PubMed ID: 23761046
[TBL] [Abstract][Full Text] [Related]
72. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.
Amital D; Fostick L; Silberman A; Calati R; Spindelegger C; Serretti A; Juven-Wetzler A; Souery D; Mendlewicz J; Montgomery S; Kasper S; Zohar J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):895-901. PubMed ID: 23121858
[TBL] [Abstract][Full Text] [Related]
73. Coenzyme Q10--a therapeutic agent.
Lance J; McCabe S; Clancy RL; Pierce J
Medsurg Nurs; 2012; 21(6):367-71. PubMed ID: 23477030
[TBL] [Abstract][Full Text] [Related]
74. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology.
Maes M; Mihaylova I; Kubera M; Leunis JC; Geffard M
J Affect Disord; 2011 Dec; 135(1-3):414-8. PubMed ID: 21930301
[TBL] [Abstract][Full Text] [Related]
75. Coenzyme Q
Gutierrez-Mariscal FM; Arenas-de Larriva AP; Limia-Perez L; Romero-Cabrera JL; Yubero-Serrano EM; López-Miranda J
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114148
[TBL] [Abstract][Full Text] [Related]
76. Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress.
Lagendijk J; Ubbink JB; Vermaak WJ
J Lipid Res; 1996 Jan; 37(1):67-75. PubMed ID: 8820103
[TBL] [Abstract][Full Text] [Related]
77. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes.
Maes M; Kubera M; Leunis JC; Berk M; Geffard M; Bosmans E
Acta Psychiatr Scand; 2013 May; 127(5):344-54. PubMed ID: 22900942
[TBL] [Abstract][Full Text] [Related]
78. Low coenzyme Q10 levels in patients with acute cardiovascular disease are associated with long-term mortality.
Shimizu M; Miyazaki T; Takagi A; Sugita Y; Ouchi S; Aikawa T; Shiozawa T; Hiki M; Takahashi S; Hiki M; Shimada K; Daida H
Heart Vessels; 2021 Mar; 36(3):401-407. PubMed ID: 32939561
[TBL] [Abstract][Full Text] [Related]
79. Determination of the coenzyme Q10 status in a large Caucasian study population.
Onur S; Niklowitz P; Fischer A; Jacobs G; Lieb W; Laudes M; Menke T; Döring F
Biofactors; 2015; 41(4):211-21. PubMed ID: 26228113
[TBL] [Abstract][Full Text] [Related]
80. Influence of adjuvant Coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode.
Jahangard L; Yasrebifar F; Haghighi M; Ranjbar A; Mehrpooya M
Mol Biol Rep; 2019 Oct; 46(5):5333-5343. PubMed ID: 31346916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
